Advertisement

Evolution, Trends, and Potential Explanations of the Increase in the Incidence of Tuberculosis: the Case of Uruguay

  • Miguel AlegrettiEmail author
  • Mariela Contrera
  • Alicia Aleman
Bacterial Infections (H Back, Section Editor)
  • 7 Downloads
Part of the following topical collections:
  1. Topical Collection on Bacterial Infections

Abstract

Purpose of review

A descriptive analysis of the trend of tuberculosis incidence in Uruguay between 1995 and 2018.

Recent findings

In 2015, World Health Organization (WHO) proposed The END TB Strategy; the Latin American countries that implemented these strategies at the first level of care have had successful outcomes in terms of the reduction in the incidence, morbidity, and mortality of the disease.

Summary

Uruguay is a striking case in the regional environment regarding tuberculosis epidemiology. The trend of tuberculosis had a turning point in 2006, which defines two clearly different periods. The first period covers the year 1995 to 2006 and shows a significant decrease in the incidence rate and the second period covers the year 2006 to 2018 and shows a significant increase in the incidence rate. The proportion of contacts of tuberculosis cases receiving prophylactic treatment, the percentage of cases lost to follow-up, and the magnitude of the bacillary burden at diagnosis moment are possible factors linked to the changes in the trend of the incidence of tuberculosis. The initiation of a gradual transfer of the responsibilities of the National Program of Tuberculosis in diagnosis, treatment, and prevention to primary care health providers in the National Integrated Health System will hopefully contribute to reverse the epidemiological situation of tuberculosis in the country.

Keywords

Tuberculosis Trends Uruguay 

Notes

Acknowledgements

We acknowledge CHLA-EP for providing national databases that made possible the analysis presented.

Compliance with Ethical Standards

Conflicts of Interest

Dr. Alegretti reports non-financial support from Comisión Honoraria de Lucha Antituberculosa, outside the submitted work. Dr. Contrera reports personal fees from Comisión Honoraria de Lucha Antituberculosa, outside the submitted work. Dr. Aleman has nothing to disclose.

Human and Animal rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    World Health Organization. Tuberculosis. Available in https://www.who.int/topics/tuberculosis/es/.
  2. 2.
    Farga V, Caminero JA. Tuberculosis. 3ra Edición ed. Santiago de Chile: Mediterraneo Ltda; 2011. 1–474.Google Scholar
  3. 3.
    Vynnycky E, Fine M. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997;119(2):183–201.CrossRefGoogle Scholar
  4. 4.••
    Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. This document describes world epidemiology of TB in order to do the monitoring of Sustainable Development Objectives and the strategies for the eradication of the global epidemic.Google Scholar
  5. 5.
    GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018;18(3):261–84.  https://doi.org/10.1016/S1473-3099(17)30703-X.CrossRefGoogle Scholar
  6. 6.
    World Health Organization. Definiciones y marco de trabajo para la notificación de tuberculosis - revisión 2013. Geneva, Switzerland: WHO; 2013. Available in: https://apps.who.int/iris/bitstream/handle/10665/111016/9789243505343_spa.pdf.
  7. 7.
    Comisión Honoraria para la Lucha Antituberculosa, Ministerio de Salud, Facultad de Medicina - UdelaR. Guía Nacional para el manejo de laTuberculosis. 3th. ed. Montevideo, Uruguay: OPS, OMS, editors; 2016.Google Scholar
  8. 8.
    World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. Geneva, Switzerland: WHO Document Production Services; 2016. Available in: https://apps.who.int/iris/bitstream/handle/10665/250125/9789241549639-eng.pdf.
  9. 9.•
    Montano A, Arrieta F, Contrera M. Informe tuberculosis 2018. Comision Honoraria de Lucha antituberculosa. Available in: http://www.chlaep.org.uy/. This document reports epidemiologic situation of Uruguay and evolution of main indicators of the disease.
  10. 10.
    World Health Organization. WHO reports 10 million TB patients successfully treated under “DOTS” 10 years after declaring TB a Global Emergency. Geneva, 2003. Available in: https://www.who.int/mediacentre/news/releases/2003/pr25/en/.
  11. 11.
    World Health Organization. La carga mundial de tuberculosis. Geneva 2005. Available in: https://www.who.int/tb/publications/tb_global_facts_sep05_sp.pdf.
  12. 12.
  13. 13.
    World Health Organization. Brochure: The WHO End TB Strategy. Available in: https://www.who.int/tb/post2015_strategy/en/.
  14. 14.
    Comisión Honoraria de Lucha Antituberculosa y Enfermedades Prevalentes. http://www.chlaep.org.uy/institucional.php.
  15. 15.
    Arrieta, F. Contrera M. Abordaje de la Tuberculosis en el Sistema Nacional Integrado de Salud. Available in: http://www.chlaep.org.uy/descargas/diaTB2018/6-Abordaje_Tuberculosis_SSNIS_DraContrera.pdf.
  16. 16.
    National Cancer Institute. Joinpoint Regression Program [Software]. Versión 4.0.4. Statistical Research and Applications, National Cancer Institute, May 2018. Disponible en: http://srab.cancer.gov/joinpoin.
  17. 17.
    Vidal C, Hoffmeister L, Biagini L. Tendencia de la mortalidad por cáncer de cuello uterino en Chile: aplicación de modelos de regresión joinpoint. Rev Panam Salud Publica. 2013;33(6):407–13.PubMedGoogle Scholar
  18. 18.
    Tuberculosis in the Americas: Regional Report 2012. Epidemiology, Control and Financing ISBN 978-92-75-11775-0.Google Scholar
  19. 19.
    New country classifications by income level: 2018-2019. Worldd Bank. Available in: https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2018-2019.
  20. 20.
    Solar O, Irwin A. A conceptual framework for action on the social determinants of health. Social Determinants of Health Discussion Paper 2 (Policy and Practice). Available in http://www.who.int/iris/handle/10665/44489.
  21. 21.
  22. 22.
    Ley N°18.211 de 5 de diciembre de 2007. Creación del Sistema Nacional Integrado de Salud y del Seguro Nacional de Salud. Available in https://www.gub.uy/ministerio-salud-publica/.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Miguel Alegretti
    • 1
    Email author
  • Mariela Contrera
    • 2
  • Alicia Aleman
    • 1
  1. 1.Departamento de Medicina Preventiva y Social, Facultad de MedicinaUniversidad de la RepúblicaMontevideoUruguay
  2. 2.Comisión Honoraria para la Lucha Antituberculosa y Enfermedades PrevalentesMontevideoUruguay

Personalised recommendations